Dnsco Pharma Private Limited
About Dnsco Pharma Private Limited
Data last updated:
Dnsco Pharma Private Limited is a private limited company based in New, Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 16 July 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1991PTC044992. Its GSTIN is 07AAACD0234E1ZD (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kanav Nangia and Neelu Nangia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H – 9 Lajpat Nagar II, New, Delhi, India – 110024.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.27 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹1.1 Cr (net margin 25.8%) and EBITDA of ₹1.86 Cr (EBITDA margin 43.5%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 30% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH – 9 Lajpat Nagar II, New, Delhi, India – 110024
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dnsco Pharma Private Limited
The main business activity of Dnsco Pharma is administrative and support service activities. In detail, this covers office administrative, office support and other business support activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Administrative and support service activities | 82 | Office administrative, office support and other business support activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Dnsco Pharma Private Limited
Dnsco Pharma has 14 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kanav Nangia Also directs: Nine Associates LLP | Director | 01 May 2013 | 13 Years 5 Months | Current |
| Neelu Nangia Also directs: Essen Medicare LLP | Director | 07 Apr 1993 | 33 Years 5 Months | Current |
| Sanjeev Nangia | Director | 01 Oct 1999 | 27 Years 0 Months | Current |
| Sakshi Gupta | Director | 01 Aug 2023 | 3 Years 2 Months | Current |
| Naiyaa Arora Also directs: Essen Medicare LLP | Director | 01 Jun 2021 | 5 Years 4 Months | Current |
| Gunpreet Kaur Sodhi | Director | 01 Jun 2022 | 4 Years 4 Months | Current |
Financials of Dnsco Pharma Private Limited FY 2025 filings available
Dnsco Pharma Private Limited reported revenue of ₹4.27 Cr (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dnsco Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 31% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dnsco Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.86 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.1 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dnsco Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 43.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 25.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dnsco Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Dnsco Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dnsco Pharma Private Limited
Dnsco Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Dnsco Pharma Private Limited
Employment history and EPFO contributions of people linked to Dnsco Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Dnsco Pharma Private Limited
Dnsco Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACD0234E1ZD | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Dnsco Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dnsco Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dnsco Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dnsco Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Dnsco Pharma Private Limited
Frequently Asked Questions about Dnsco Pharma Private Limited
Dnsco Pharma is an active private limited company based in New, Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 16 July 1991 (35+ years old) and is registered under CIN U74899DL1991PTC044992.
Dnsco Pharma reported revenue of ₹4.27 Cr for FY 2025 (up 31% YoY).
Dnsco Pharma has 14 current directors:
- Kanav Nangia - Director
- Neelu Nangia - Director
- Sanjeev Nangia - Director
- Sakshi Gupta - Director
- Naiyaa Arora - Director
- Gunpreet Kaur Sodhi - Director
- Hina Nangia - Director
- Karan Nangia - Additional Director
- Nikita Nangia - Director
- Sandeep Nangia - Director
- Rohan Nangia - Additional Director
- Sanjay Nangia - Additional Director
- Sabina Nangia - Additional Director
- Anjum Nangia - Additional Director
Dnsco Pharma reported a net profit of ₹1.1 Cr (net margin 25.8%) and EBITDA of ₹1.86 Cr (EBITDA margin 43.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dnsco Pharma is 28% over three years and 30% over five years. In the latest year (FY 2025) revenue rose 31%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dnsco Pharma is 07AAACD0234E1ZD, registered in Delhi.
The CIN (Corporate Identification Number) of Dnsco Pharma is U74899DL1991PTC044992. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dnsco Pharma was incorporated on 16 July 1991, making it 35+ years old. It is registered with the Registrar of Companies, Delhi.
The registered office of Dnsco Pharma is at H – 9 Lajpat Nagar II, New, Delhi, India – 110024.